17.01.2014 Views

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

similar effects within different populations.<br />

Although lifetime physical activity<br />

is desirable, beginning re c re a t i o n a l<br />

physical activity after the menopause<br />

can probably be beneficial for both<br />

weight control and <strong>breast</strong> cancer risk<br />

reduction {1292}.<br />

Fig. 1.07 Age distribution of benign and maligmant <strong>breast</strong> lesions in patients presenting with a discrete<br />

<strong>breast</strong> lump. From Dixon and Sainsbury {707}.<br />

Endogenous hormones<br />

There is overwhelming evidence from<br />

epidemiological studies that sex steroids<br />

( a n d rogens, estrogens, pro g e s t o g e n s )<br />

have an important role in the development<br />

of <strong>breast</strong> tumours. Breast cancer<br />

incidence rates rise more steeply with<br />

age before menopause than after, when<br />

ovarian synthesis of estrogens and progesterone<br />

ceases and ovarian androgen<br />

production gradually diminishes {1447}.<br />

The estrogen excess hypothesis is central,<br />

stipulating that <strong>breast</strong> cancer risk<br />

depends directly on <strong>breast</strong> tissue expos<br />

u re to estrogens. In vitro studies show<br />

i n c reased <strong>breast</strong> cell proliferation and<br />

inhibition of apoptosis. Animal studies<br />

show increased rates of tumour development<br />

when estrogens are administere d .<br />

The risk is higher among postmenopausal<br />

women who have elevated plasma levels<br />

of testosterone and andro s t e n e d i o n e ,<br />

reduced levels of sex horm o n e - b i n d i n g<br />

globulin (SHBG), and increased levels of<br />

o e s t rone, oestradiol, and bioavailable<br />

oestradiol not bound to SHBG.<br />

A second major theory, the estro g e n<br />

plus progestogen hypothesis {255,<br />

1446}, postulates that, compared to<br />

e x p o s u re to estrogens alone (as in postmenopausal<br />

women not using exogenous<br />

hormones), risk of <strong>breast</strong> cancer is<br />

f u rther increased in women who have<br />

elevated plasma and tissue levels of<br />

e s t rogens in combination with pro g e s t o-<br />

gens. This theory is supported by observations<br />

that proliferation of mammary<br />

epithelial cells is increased during the<br />

luteal phase of the menstrual cycle,<br />

c o m p a red to the follicular phase.<br />

Among premenopausal women, several<br />

studies have not shown any clear association<br />

between <strong>breast</strong> cancer risk and<br />

c i rculating levels of androgens, estrogens,<br />

or pro g e s t e rone {255,1183,2448,<br />

2 6 1 3 , 2 9 0 9 } .<br />

A metabolic consequence of excess<br />

body weight and lack of physical activity<br />

is development of insulin re s i s t a n c e .<br />

Elevated insulin levels, may lead to<br />

increased ovarian and/or adrenal synthesis<br />

of sex steroids, particularly of androgens,<br />

and decrease the hepatic synthesis<br />

and circulating levels of SHBG<br />

{1376}. Especially in postmenopausal<br />

women, elevated plasma andro g e n s<br />

lead to increased estrogen formation in<br />

adipose tissue, and hence to increased<br />

levels of oestrone and oestradiol. The<br />

hypothesis that chronic hyperinsulinemia<br />

might explain the observed associations<br />

of <strong>breast</strong> cancer risk with low plasma<br />

SHBG and elevated androgens and<br />

e s t rogens, among postmenopausal<br />

women {1376} has, however, received<br />

only limited support {661,1377}. Insulingrowth<br />

factor-I (IGF-I) and IGF-binding<br />

proteins (IGFBP) appear to be significant<br />

risk predictors {1127,1377}.<br />

F u t u re adult cancer risk is in part set by<br />

conditions of exposure in utero. The preventive<br />

effect of gravidic toxaemia is re c-<br />

ognized {1288} and since the 1950s studies<br />

have incriminated high birth weight as<br />

a risk factor for cancer, in particular of the<br />

b reast {1857}. Similarly, among twins, the<br />

risk of <strong>breast</strong> cancer may be affected by<br />

the type of twinning (dizygotic versus<br />

monozygotic) and sex of the dizygotic<br />

twin {429}. A study of maternal pre g n a n-<br />

cy hormone levels in China and the<br />

United States of America (USA) did not<br />

find, however, the expected higher levels<br />

in the USA but rather the reverse {1676}.<br />

Another important period is adolescence,<br />

w h e re diet may play a role either dire c t l y<br />

or possibly indirectly through a modification<br />

of growth velocity {242}.<br />

Some specific exposures<br />

Only limited data is available on specific<br />

exposures in relation to <strong>breast</strong> cancer.<br />

Long-term follow-up of women exposed<br />

to the Hiroshima or Nagasaki nuclear<br />

explosions indicates an increased risk of<br />

<strong>breast</strong> cancer, in particular for women<br />

exposed around puberty {2938}.<br />

Similarly, exposure as a result of treatment<br />

and surveillance of tuberculosis is<br />

associated with risk {304}. Yet there is little<br />

evidence for a different pattern of risk<br />

as a function of fractionated versus one<br />

time only irradiation {1678}. Systematic<br />

reviews on occupation and <strong>breast</strong> cancer<br />

are few, indicating an increased risk<br />

for selected occupations and specific<br />

chemical and physical exposures. This<br />

data contrasts with the long-held view<br />

that risk of <strong>breast</strong> cancer is related to<br />

social class, with higher risk for execu-<br />

Table 1.01<br />

Frequency of symptoms of women presenting in a<br />

<strong>breast</strong> clinic {288,698}.<br />

Lump 60-70%<br />

Pain 14-18%<br />

Nipple problems 7-9%<br />

Deformity 1%<br />

Inflammation 1%<br />

Family history 3-14%<br />

16 Tumours of the <strong>breast</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!